Early symptomatic neurosyphilis and ocular syphilis: A comparative study between HIV-positive and HIV-negative patients.
Adult
Anti-Bacterial Agents
/ therapeutic use
Cranial Nerves
/ pathology
Eye Infections, Bacterial
/ drug therapy
Female
HIV Infections
/ epidemiology
HIV Seropositivity
/ epidemiology
Humans
Male
Meningitis
/ epidemiology
Middle Aged
Neurosyphilis
/ drug therapy
Paresthesia
/ epidemiology
Sexual and Gender Minorities
/ statistics & numerical data
Syphilis
/ drug therapy
Treatment Outcome
Uveitis
/ epidemiology
Visual Acuity
HIV
Neurosyphilis
Ocular syphilis
Syphilis
Journal
Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
02
01
2020
revised:
03
05
2020
accepted:
14
10
2020
pubmed:
27
11
2020
medline:
8
10
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
Since the 2000s, there has been an increase in prevalence of neurosyphilis (NS) and ocular syphilis (OS). As data about symptomatic NS/OS is limited, this study aims to assess the characteristics of symptomatic NS/OS, according to HIV status. We compared the clinical and biological presentation of early symptomatic NS/OS and its outcome in HIV-positive and HIV-negative patients. Ninety-six patients (93% men, 49% HIV-positive) were included from 2000 to 2016 in two centers, with 67 (69%) having OS, 15 (16%) NS, and 14 (14%) both. HIV-positive patients were younger (P=0.006) and more likely to be males having sex with males (P=0.00048) or to have a history of syphilis (P=0.01). Among 81 OS, there were 43 posterior uveitis (57%), and bilateral involvement was more common in HIV-positive patients (62% versus 38%, P=0.045). Among 29 NS there were 21 cases of cranial nerve involvement (72%), seven meningitis (24%) and 11 paresthesia (38%). Involvement of the VIII HIV infection has no consequence on the outcome of NS and OS. Sequelae are common, emphasizing the importance of prevention, and screening, and questioning enhanced treatment.
Identifiants
pubmed: 33239175
pii: S0399-077X(20)30756-3
doi: 10.1016/j.medmal.2020.10.016
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
351-356Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.